People
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
26 June 2026 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) said on Friday that it will request a re-examination of the European Medicines Agency's Committee for Medicin...
Sensei Biotherapeutics changes name to Faeth Therapeutics
15 June 2026 - Clinical-stage biotechnology company Sensei Biotherapeutics Inc (Nasdaq:SNSE) announced on Monday that it has changed its corporate name to Faeth Therapeutics Inc, with its common stock...
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
20 May 2026 - Datavault AI Inc (NASDAQ: DVLT), a provider of data monetisation, credentialing, digital engagement and real-world asset (RWA) tokenisation technologies, announced on Wednesday that it h...
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
15 May 2026 - Intensity Therapeutics Inc (Nasdaq:INTS), a late-stage clinical biotechnology company, announced on Thursday that it has been named a winner of the 2026 GHP Magazine Healthcare & Pha...
Sprout Pharmaceuticals named one of TIME's most influential health and life sciences companies of 2026
30 April 2026 - TIME magazine has named women's health specialist Sprout Pharmaceuticals among 10 organisations globally shaping the future of health and life sciences.This recognition follows a ...
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
22 April 2026 - Biopharmaceutical company Solvonis Therapeutics plc (LSE: SVNS) announced on Wednesday that it has appointed US-based research and investor engagement firm Water Tower Research LLC to ...